Status:
COMPLETED
Implication of Left veNtricle Vortex Flow Guided aNticOagulation Therapy for preVenting Apical Thrombus Formation In Patients With Acute myOcardial infarctioN: Multicenter Prospective Randomized Clinical Trial; INNOVATION Study
Lead Sponsor:
Yonsei University
Conditions:
Apical Thrombus Formation
Acute Myocardial Infarction
Eligibility:
All Genders
30-90 years
Brief Summary
Implication of left veNtricle vortex flow guided aNticOagulation therapy for preVenting Apical Thrombus formation In patients with acute myOcardial infarctioN: Multicenter Prospective Randomized Clini...
Eligibility Criteria
Inclusion
- Patient is ≥ 30 years old
- Acute anterior wall myocardial infarction showing akinetic or dyskinetic apical wall motion abnormalities on an initial transthoracic echocardiogram
- Left ventricular ejection fraction less than 40%
Exclusion
- Prior history of myocardial infarction
- Chronic medication with Coumadin
- Contraindication of contrast echocardiography
- Significant atrial or ventricular arrhythmia
- Valvular heart disease more than moderate degree
- Decompensated heart failure
- Very poor echo window, which cannot evaluate the presence of apical thrombus
Key Trial Info
Start Date :
February 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT01869998
Start Date
February 1 2012
End Date
September 1 2015
Last Update
May 10 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Severance cardiovascular hospital
Seoul, Seoul, South Korea, 120-752